Adding testosterone to HT may counteract harmful breast effects

Article

Adding testosterone to combination hormone therapy with estrogen and progesterone may counteract breast cell proliferation in postmenopausal women, according to the results of a 6-month, prospective, randomized, double-blind, placebo-controlled trial.

In the study, 99 post-menopausal women received continuous combined estradiol 2 mg/norethisterone acetate 1 mg and either a testosterone patch releasing 300 µg/24 hours or a placebo patch.

The women in the placebo group had more than a fivefold increase in total breast cell proliferation from a median value of 1.1% at baseline to a median of 6.2% after 6 months (P<0.001). No such increase occurred in the testosterone group (1.6% vs. 2.0%). Proliferative changes were noted in both epithelial and stromal cells.

Until such time as more data are available, caution should be exercised in adding testosterone to traditional hormone therapy regimens.

Hofling M, Hirschberg AL, Skoog L, et al. Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women. Menopause. 2007;14:183-190.

Burger HG. Should testosterone be added to estrogen-progestin therapy for breast protection? Menopause. 2007;14:159-162.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Neal Barnard, MD, FACC, highlights AMA's new breast cancer prevention guidelines | Image Credit: pcrm.org.
Zachary Wagner, PhD, discusses the harms of bias in reproductive care | Image Credit: ornsife.usc.edu.
Ciera Kirkpatrick, PhD, shows how TikTok is transforming cervical cancer awareness | Image Credit: linkedin.com.
Maria Gallo, PhD, discusses high attendance at crisis pregnancy centers | Image Credit: © x.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.